Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01194960
What this trial is testing

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Hormone Refractory Prostate Cancer
Oxford BioMedica 25
Testing effectiveness (Phase 2)Study completedNCT01487720
What this trial is testing

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Asan Medical Center 33
Large-scale testing (Phase 3)Study completedNCT00002760
What this trial is testing

Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 260
Testing effectiveness (Phase 2)Study completedNCT00017576
What this trial is testing

Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 19
Large-scale testing (Phase 3)Study completedNCT02887976
What this trial is testing

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Who this might be right for
Prostate Cancer
GU Research Network, LLC 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012321
What this trial is testing

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Who this might be right for
Prostate Cancer Metastatic Castration-ResistantAbnormal DNA RepairMetastatic Prostate Carcinoma+1 more
Northwestern University 70
Testing effectiveness (Phase 2)Looking for participantsNCT07441889
What this trial is testing

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Who this might be right for
Breast CancerProstate Cancer
University of Virginia 23
Early research (Phase 1)Looking for participantsNCT04729114
What this trial is testing

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration Resistant Prostate CancerMetastatic Castration-sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 174
Early research (Phase 1)Study completedNCT04397276
What this trial is testing

JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT00416533
What this trial is testing

Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 47
Testing effectiveness (Phase 2)Ended earlyNCT03572478
What this trial is testing

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Who this might be right for
Prostate CancerEndometrial Cancer
University of Chicago 12
Large-scale testing (Phase 3)Study completedNCT00887198
What this trial is testing

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 1,088
Testing effectiveness (Phase 2)Study completedNCT02962284
What this trial is testing

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

Who this might be right for
Metastatic Prostate Cancer
Sun Pharmaceutical Industries Limited 20
Not applicableStudy completedNCT02702908
What this trial is testing

Second Primary Cancers in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bayer 6,442
Testing effectiveness (Phase 2)Looking for participantsNCT07717268
What this trial is testing

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic 51
Testing effectiveness (Phase 2)Study completedNCT00488982
What this trial is testing

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Prostate Cancer
University of California, San Francisco 125
Testing effectiveness (Phase 2)Ended earlyNCT01650350
What this trial is testing

Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer

Who this might be right for
MelanomaProstate CancerRenal Cancer
Brown University 7
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750
What this trial is testing

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 61
Testing effectiveness (Phase 2)Ended earlyNCT01119118
What this trial is testing

ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 6
Early research (Phase 1)Looking for participantsNCT05805371
What this trial is testing

PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
City of Hope Medical Center 21
Next Page